Molecular dynamics simulations to decipher the structural and functional consequences of pathogenic missense mutations in the galactosylceramidase (GALC) protein causing Krabbe’s disease

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. doi:10.1016/j.softx.2015.06.001
   Google Scholar
• Agrahari, A. K., Kumar, A., Ramamoorthy, S., Zayed, H., & Priya Doss C, G. (2018). Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot–Marie-tooth disease: A computational study. Journal of Theoretical Biology, 437, 305–317. doi:10.1016/j.jtbi.2017.10.028
   PubMed Web of Science ®Google Scholar
• Agrahari, A. K., Muskan, M., Priya Doss C, G., Siva, R., & Zayed, H. (2018). Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: A molecular modeling and dynamics approach. Metabolic Brain Disease, 33(5), 1443–1457. doi:10.1007/s11011-018-0251-1
   PubMed Web of Science ®Google Scholar
• Agrahari, A. K., Sneha, P., Priya Doss C, G., Siva, R., & Zayed, H. (2018). A profound computational study to prioritize the disease-causing mutations in PRPS1 gene. Metabolic Brain Disease, 33(2), 589–600. doi:10.1007/s11011-017-0121-2
   PubMed Web of Science ®Google Scholar
• Ali, S. K., Sneha, P., Christy, J. P., Zayed, H., & Doss, C. G. P. (2017). Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. Journal of Biomolecular Structure and Dynamics, 35(12), 2714–2724. doi:10.1080/07391102.2016.1229634
   PubMed Web of Science ®Google Scholar
• Bendl, J., Stourac, J., Salanda, O., Pavelka, A., Wieben, E. D., Zendulka, J., Brezovsky, J., & Damborsky, J. (2014). PredictSNP: Robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Computational Biology, 10(1), e1003440. doi:10.1371/journal.pcbi.1003440
   PubMed Web of Science ®Google Scholar
• Benjamin, E. R., Khanna, R., Schilling, A., Flanagan, J. J., Pellegrino, L. J., Brignol, N., Lun, Y., Guillen, D., Ranes, B. E., Frascella, M., Soska, R., Feng, J., Dungan, L., Young, B., Lockhart, D. J., & Valenzano, K. J. (2012). Co-administration with the pharmacological chaperone AT1001 increases recombinant human A -galactosidase A tissue uptake and improves substrate reduction in Fabry mice. Molecular Therapy, 20(4), 717–726. doi:10.1038/mt.2011.271
   PubMed Web of Science ®Google Scholar
• Bhardwaj, V., & Purohit, R. (2019). Computational investigation on effect of mutations in PCNA resulting in structural perturbations and inhibition of mismatch repair pathway. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2019.1621210
   PubMed Web of Science ®Google Scholar
• Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., & Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research, 42(W1), W252–258. (Web Server issue). doi:10.1093/nar/gku340
   PubMed Web of Science ®Google Scholar
• Bernier V, Lagacé M, Bichet DG, Bouvier M. Pharmacological chaperones: potential treatment for conformational diseases. Trends in Endocrinology & Metabolism. 2004 Jul 1;15(5):222–8.
   Google Scholar
• Botstein, D., & Risch, N. (2003). Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature genetics, 33(3), 228–237.
   Google Scholar
• Burke, D. F., Worth, C. L., Priego, E.-M., Cheng, T., Smink, L. J., Todd, J. A., & Blundell, T. L. (2007). Genome bioinformatic analysis of nonsynonymous SNPs. BMC Bioinformatics, 8(1), 301. doi:10.1186/1471-2105-8-301
   PubMedGoogle Scholar
• Chen, C. W., Lin, J., & Chu, Y. W. (2013). iStable: Off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics, 14(Suppl 2), S5. doi:10.1186/1471-2105-14-S2-S5
   PubMed Web of Science ®Google Scholar
• Chen, Y. Q., & Wenger, D. A. (1993). Galactocerebrosidase from human urine: Purification and partial characterization. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1170(1), 53–61. doi:10.1016/0005-2760(93)90175-9
   PubMedGoogle Scholar
• Chen, Y. Q., Rafi, M. A., de Gala, G., & Wenger, D. A. (1993). Cloning and expression cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Human Molecular Genetics, 2(11), 1841–1846. doi:10.1093/hmg/2.11.1841
   PubMed Web of Science ®Google Scholar
• Collins, F. S., Brooks, L. D., & Chakravarti, A. (1998). A DNA polymorphism discovery resource for research on human genetic variation. Genome Research, 8(12), 1229–1231. doi:10.1101/gr.8.12.1229
   PubMed Web of Science ®Google Scholar
• de Brevern, A. G. (2016). Extension of the classical classification of β-turns. Scientific Reports, 6(1), 1–15. doi:10.1038/srep33191
   PubMedGoogle Scholar
• Deane, J. E., Graham, S. C., Kim, N. N., Stein, P. E., McNair, R., Cachon-Gonzalez, M. B., Cox, T. M., & Read, R. J. (2011). Insights into Krabbe disease from structures of galactocerebrosidase. Proceedings of the National Academy of Sciences, 108(37), 15169–15173. doi:10.1073/pnas.1105639108
   PubMed Web of Science ®Google Scholar
• Doss, C. G. P., Alasmar, D. R., Bux, R. I., Sneha, P., Bakhsh, F. D., Al-Azwani, I., Bekay, R. E., & Zayed, H. (2016). Genetic epidemiology of glucose-6-phosphate dehydrogenase deficiency in the Arab world. Scientific Reports, 6(1), 37284. doi:10.1038/srep37284
   PubMedGoogle Scholar
• Escolar, M. L., Kiely, B. T., Shawgo, E., Hong, X., Gelb, M. H., Orsini, J. J., Matern, D., & Poe, M. D. (2017). Psychosine, a marker of Krabbe phenotype and treatment effect. Molecular Genetics and Metabolism, 121(3), 271–278. doi:10.1016/j.ymgme.2017.05.015
   PubMed Web of Science ®Google Scholar
• Fu, H., Grimsley, G. R., Razvi, A., Scholtz, J. M., & Pace, C. N. (2009). Increasing protein stability by improving beta-turns. Proteins: Structure, Function, and Bioinformatics, 77(3), 491–498. doi:10.1002/prot.22509
   PubMed Web of Science ®Google Scholar
• Fu, L., Inui, K., Nishigaki, T., Tatsumi, N., Tsukamoto, H., Kokubu, C., Muramatsu, T., & Okada, S. (1999). Molecular heterogeneity of Krabbe disease. Journal of Inherited Metabolic Disease, 22(2), 155–162. doi:10.1023/A:1005449919660
   PubMed Web of Science ®Google Scholar
• Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor-Shental, D., Martz, E., & Ben-Tal, N. (2003). ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics, 19(1), 163–164. doi:10.1093/bioinformatics/19.1.163
   PubMed Web of Science ®Google Scholar
• Graziano, A. C. E., & Cardile, V. (2015). History, genetic, and recent advances on Krabbe disease. Gene, 555(1), 2–13. doi:10.1016/j.gene.2014.09.046
   PubMed Web of Science ®Google Scholar
• Graziano, A. C. E., Pannuzzo, G., Avola, R., & Cardile, V. (2016). Chaperones as potential therapeutics for Krabbe disease. Journal of Neuroscience Research, 94(11), 1220–1230. doi:10.1002/jnr.23755
   PubMed Web of Science ®Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis, 18(15), 2714–2723. doi:10.1002/elps.1150181505
   PubMed Web of Science ®Google Scholar
• Guharoy, M., & Chakrabarti, P. (2005). Conservation and relative importance of residues across protein-protein interfaces. Proceedings of the National Academy of Sciences of Sciences, 102(43), 15447–15452. doi:10.1073/pnas.0505425102
   PubMed Web of Science ®Google Scholar
• Hill, C. H., Viuff, A. H., Spratley, S. J., Salamone, S., Christensen, S. H., Read, R. J., Moriarty, N. W., Jensen, H. H., & Deane, J. E. (2015). Azasugar inhibitors as pharmacological chaperones for Krabbe disease. Chemical Science, 6(5), 3075–3086. doi:10.1039/C5SC00754B
   PubMed Web of Science ®Google Scholar
• Hossain, M. A., Higaki, K., Saito, S., Ohno, K., Sakuraba, H., Nanba, E., Suzuki, Y., Ozono, K., & Sakai, N. (2015). Chaperone therapy for Krabbe disease: Potential for late-onset GALC mutations. Journal of Human Genetics, 60(9), 539–545. doi:10.1038/jhg.2015.61
   PubMed Web of Science ®Google Scholar
• Jang, D. S., Ye, W., Guimei, T., Solomon, M., Southall, N., Hu, X., Marugan, J., Ferrer, M., Maegawa, G. H. B. (2016). Cell‐based high‐throughput screening identifies galactocerebrosidase enhancers as potential small‐molecule therapies for K rabbe's disease. Journal of neuroscience research, 94(11), 1231–1245.
   Google Scholar
• Kamal, M. Z., Mohammad, T. A. S., Krishnamoorthy, G., & Rao, N. M. (2012). Role of active site rigidity in activity: MD simulation and fluorescence study on a lipase mutant. PLoS One, 7(4), e35188. doi:10.1371/journal.pone.0035188
   PubMed Web of Science ®Google Scholar
• Kardas, F., Uzak, A. S., Hossain, A., Sakai, N., Canpolat, M., Yklmaz, A., Hossain, M. A., Sakai, N., Canpolat, M., & Yklmaz, A. (2013). A novel homozygous GALC mutation: Very early onset and rapidly progressive Krabbe disease. Gene, 517(1), 125–127. doi:10.1016/j.gene.2012.12.040
   PubMed Web of Science ®Google Scholar
• Kobayashi, T., Yamanaka, T., Jacobs, J. M., Teixeira, F., & Suzuki, K. (1980). The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Research, 202(2), 479–483. doi:10.1016/0006-8993(80)90159-6
   PubMed Web of Science ®Google Scholar
• Lee, E., Fuller, M., Carr, M., Manavis, J., & Finnie, J. (2019). Globoid cell leukodystrophy (Krabbe disease) in a Merino sheep. Journal of Veterinary Diagnostic Investigation, 31(1), 118–121.
   Google Scholar
• Lee, W. C., Kang, D., Causevic, E., Herdt, A. R., Eckman, E. A., & Eckman, C. B. (2010). Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. Journal of Neuroscience, 30(16), 5489–5497. doi:10.1523/JNEUROSCI.6383-09.2010
   PubMed Web of Science ®Google Scholar
• Liao, P., Gelinas, J., & Sirrs, S. (2014). Phenotypic variability of Krabbe disease across the lifespan. Canadian Journal of Neurological Sciences/Journal Canadien Des Sciences Neurologiques, 41(1), 5–12. doi:10.1017/S0317167100016188
   Google Scholar
• Lobanov, M. I., Bogatyreva, N. S., & Galzitskaia, O. V. (2008, Jul–Aug). Radius of gyration is indicator of compactness of protein structure. Molekuliarnaia Biologiia, 42(4), 701–706.
   PubMed Web of Science ®Google Scholar
• Luzi, P., Rafi, M. A., & Wenger, D. A. (1995). Structure and organization of the human galactocerebrosidase (GALC) gene. Genomics, 26(2), 407–409. doi:10.1016/0888-7543(95)80230-J
   PubMed Web of Science ®Google Scholar
• Malde, A. K., Zuo, L., Breeze, M., Stroet, M., Poger, D., Nair, P. C., Oostenbrink, C., & Mark, A. E. (2011). An automated force field topology builder (ATB) and repository: Version 1.0. Journal of Chemical Theory and Computation, 7(12), 4026–4037. doi:10.1021/ct200196m
   PubMed Web of Science ®Google Scholar
• Mikulka, C. R., & Sands, M. S. (2016). Treatment for Krabbe’s disease: Finding the combination. Journal of Neuroscience Research, 94(11), 1126–1137. doi:10.1002/jnr.23822
   PubMed Web of Science ®Google Scholar
• Mohamed, F. E., Al-Gazali, L., Al-Jasmi, F., & Ali, B. R. (2017). Pharmaceutical chaperones and proteostasis regulators in the therapy of lysosomal storage disorders: Current perspective and future promises. Frontiers in Pharmacology, 8(JUL), 1–17. doi:10.3389/fphar.2017.00448
   PubMedGoogle Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Munshi, C., Thiel, D. J., Mathews, I. I., Aarhus, R., Walseth, T. F., & Lee, H. C. (1999). Characterization of the active site of ADP-ribosyl cyclase. Journal of Biological Chemistry, 274(43), 30770–30777. doi:10.1074/jbc.274.43.30770
   PubMed Web of Science ®Google Scholar
• Pace, C. N., Fu, H., Fryar, K. L., Landua, J., Trevino, S. R., Shirley, B. A., Hendricks, M. M., Iimura, S., Gajiwala, K., Scholtz, J. M., & Grimsley, G. R. (2011). Contribution of hydrophobic interactions to protein stability. Journal of Molecular Biology, 408(3), 514–528. doi:10.1016/j.jmb.2011.02.053
   PubMed Web of Science ®Google Scholar
• Parenti, G., Fecarotta, S., Marca, G., Rossi, B., Ascione, S., Donati, M. A., Morandi, L. O., Ravaglia, S., Pichiecchio, A., Ombrone, D., Sacchini, M., Pasanisi, M. B., Filippi, P., De, Danesino, C., Casa, R., Della, Romano, A., Mollica, C., Rosa, M., Agovino, T., … … Ndria, G. (2014). A chaperone enhances blood α -glucosidase activity in pompe disease patients treated with enzyme replacement therapy. Molecular Therapy, 22(11), 2004–2012. doi:10.1038/mt.2014.138
   PubMed Web of Science ®Google Scholar
• Pritchard, J. K., Cox, N. J. (2002). The allelic architecture of human disease genes: Common disease–common variant… or not?. Human Molecular Genetics, 11(20), 2417–2423. doi:10.1093/hmg/11.20.2417
   PubMed Web of Science ®Google Scholar
• Priya Doss C, G., & Zayed, H. (2017). Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metabolic Brain Disease, 32(6), 2105–2118. doi:10.1007/s11011-017-0090-5
   PubMed Web of Science ®Google Scholar
• Rajendran, V., Gopalakrishnan, C., & Purohit, R. (2016). Impact of point mutation P29S in RAC1 on tumorigenesis. Tumor Biology, 37(11), 15293–15304. doi:10.1007/s13277-016-5329-y
   PubMedGoogle Scholar
• Roden, D. M., Wilke, R. A., Kroemer, H. K., & Stein, C. M. (2011). Pharmacogenomics. Circulation, 123(15), 1661–1670. doi:10.1161/CIRCULATIONAHA.109.914820
   PubMed Web of Science ®Google Scholar
• Sakai, N., Inui, K., Fujii, N., Fukushima, H., Nishimoto, J., Yanagihara, I., Isegawa, Y., Iwamatsu, A., & Okada, S. (1994). Krabbe disease: Isolation and characterization of a full-length cDNA for human galactocerebrosidase. Biochemical and Biophysical Research Communications, 198(2), 485–491. doi:10.1006/bbrc.1994.1071
   PubMed Web of Science ®Google Scholar
• Santambrogio, S., Ricca, A., Maderna, C., Ieraci, A., Aureli, M., Sonnino, S., Kulik, W., Aimar, P., Bonfanti, L., Martino, S., & Gritti, A. (2012). The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development. Human Molecular Genetics, 21(21), 4732–4750. doi:10.1093/hmg/dds313
   PubMed Web of Science ®Google Scholar
• Sharma, J., Bhardwaj, V., & Purohit, R. (2019). Structural perturbations due to mutation (H1047R) in phosphoinositide-3-kinase (PI3Kα) and its involvement in oncogenesis: An in silico insight. ACS Omega, 4(14), 15815–15823. doi:10.1021/acsomega.9b01439
   PubMed Web of Science ®Google Scholar
• Singh, R., Bhardwaj, V., Das, P., & Purohit, R. (2019). Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: A computational perspective. Journal of Biomolecular Structure and Dynamics, 1–10. 10.1080/07391102.2019.1696709
   PubMed Web of Science ®Google Scholar
• Sneha, P., Ebrahimi, E. A., Ghazala, S. A., Thirumal Kumar, D., Ramamoorthy, S., Priya Doss C., G., & Zayed, H. (2018a). Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2. Journal of Cellular Biochemistry, 119(9), 7585–7598. doi:10.1002/jcb.27097
   PubMed Web of Science ®Google Scholar
• Sneha, P., Thirumal Kumar, D., Priya Doss C., G., & Zayed, H. (2017). Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach. PLos One, 12(4), e0174953. doi:10.1371/journal.pone.0174953
   PubMed Web of Science ®Google Scholar
• Sneha, P., Zenith, T. U., Abu Habib, U. S., Evangeline, J., Thirumal Kumar, D., Priya Doss C, G., Siva, R., & Zayed, H. (2018b). Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach. Metabolic Brain Disease, 33(6), 1823–1834. doi:10.1007/s11011-018-0285-4
   PubMed Web of Science ®Google Scholar
• Suzuki, K. (1998). Twenty five years of the “psychosine hypothesis”: A personal perspective of its history and present status. Neurochemical Research, 23(3), 251–259.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., Nagara, H., Kobayashi, T., & Goto, I. (1988). The twitcher mouse: Accumulation of galactosylsphingosine and pathology of the sciatic nerve. Brain Research, 454(1-2), 340–346. doi:10.1016/0006-8993(88)90835-9
   PubMed Web of Science ®Google Scholar
• Tanwar, G., & Purohit, R. (2019). Gain of native conformation of Aurora A S155R mutant by small molecules. Journal of Cellular Biochemistry, 120(7), 11104–11114. doi:10.1002/jcb.28387
   PubMed Web of Science ®Google Scholar
• Tappino, B., Biancheri, R., Mort, M., Regis, S., Corsolini, F., Rossi, A., Stroppiano, M., Lualdi, S., Fiumara, A., Bembi, B., Di Rocco, M., Cooper, D. N., & Filocamo, M. (2010). Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease. Human Mutation (12), 31. doi:10.1002/humu.21367
   Web of Science ®Google Scholar
• Thirumal Kumar, D., & Priya Doss C, G. (2017). Role of E542 and E545 missense mutations of PIK3CA in breast cancer: A comparative computational approach. Journal of Biomolecular Structure and Dynamics, 35(12), 2745–2757. doi:10.1080/07391102.2016.1231082
   PubMed Web of Science ®Google Scholar
• Thirumal Kumar, D., Eldous, H. G., Mahgoub, Z. A., Priya Doss C, G., & Zayed, H. (2018). Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases. Metabolic Brain Disease, 33(6), 1835–1847. doi:10.1007/s11011-018-0286-3
   PubMed Web of Science ®Google Scholar
• Thirumal Kumar, D., Jain, N., Udaya Kumar, S. U., Priya Doss C, G., & Zayed, H. (2019). Identification of potential inhibitors against pathogenic missense mutations of PMM2 using a structure-based virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1–17. 10.1080/07391102.2019.1708797
   Google Scholar
• Thirumal Kumar, D., Jerushah Emerald, L., Priya Doss C, G., Sneha, P., Siva, R., Charles Emmanuel Jebaraj, W., & Zayed, H. (2018). Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2. Metabolic Brain Disease, 33(5), 1699–1710. doi:10.1007/s11011-018-0278-3
   PubMed Web of Science ®Google Scholar
• Thirumal Kumar, D., Udhaya Kumar, S., Nishaat Laeeque, A. S., Apurva Abhay, S., Bithia, R., Magesh, R., Kumar, M., Zayed, H., & Priya Doss C, G. (2020). Chapter nine - Computational model to analyze and characterize the functional mutations of NOD2 protein causing inflammatory disorder – Blau syndrome. In R. Donev (Ed.), Advances in protein chemistry and structural biology. (Vol. 120, pp. 379–408). Academic Press. 10.1016/bs.apcsb.2019.11.005
   Google Scholar
• Udhaya Kumar, S., Thirumal Kumar, D., Mandal, P. D., Sankar, S., Haldar, R., Kamaraj, B., Walter, C. E. J., Siva, R., Priya Doss C, G., & Zayed, H. (2020). Chapter eight - Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene. In R. Donev (Ed.), Advances in protein chemistry and structural biology (Vol. 120, pp. 349–377). Academic Press. 10.1016/bs.apcsb.2019.11.004
   Google Scholar
• Udhaya Kumar, S., Thirumal Kumar, D., Ramamoorthy, S., Priya Doss C, G., & Zayed, H. (2020). An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia. Computers in Biology and Medicine, 117, 103583. doi:10.1016/j.compbiomed.2019.103583
   PubMed Web of Science ®Google Scholar
• Valenzano, K. J., Khanna, R., Powe Jr, A. C., Boyd, R., Lee, G., Flanagan, J. J., & Benjamin, E. R. (2011). Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders. Assay and drug development technologies, 9(3), 213–235.
   Google Scholar
• Visigalli, I., Ungari, S., Martino, S., Park, H., Cesani, M., Gentner, B., Sergi, L. S., Orlacchio, A., Naldini, L., & Biffi, A. (2010). The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche. Blood, 116(11), 1857–1866. doi:10.1182/blood-2009-12-256461
   PubMed Web of Science ®Google Scholar
• Zaki, O. K., Krishnamoorthy, N., El Abd, H. S., Harche, S. A., Mattar, R. A., Al Disi, R. S., Nofal, M. Y., El Bekay, R., Ahmed, K. A., Priya Doss C, G., & Zayed, H. (2017). Two patients with Canavan disease and structural modeling of a novel mutation. Metabolic Brain Disease, 32(1), 171–177. doi:10.1007/s11011-016-9896-9
   PubMed Web of Science ®Google Scholar
• Zaki, O. K., Priya Doss C, G., Ali, S. A., Murad, G. G., Elashi, S. A., Ebnou, M. S. A., Kumar D, T., Khalifa, O., Gamal, R., El Abd, H. S. A., Nasr, B. N., & Zayed, H. (2017). Genotype–phenotype correlation in patients with isovaleric acidaemia: Comparative structural modelling and computational analysis of novel variants. Human Molecular Genetics, 26(16), 3105–3115. doi:10.1093/hmg/ddx195
   PubMed Web of Science ®Google Scholar
• Zayed, H. (2015). Krabbe disease in the Arab World. Journal of Pediatric Genetics, 04(01), 001–008. doi:10.1055/s-0035-1554981
   Google Scholar